Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Accumulating evidence shows that Mesenchymal Stem/Stromal Cells (MSCs) exert their therapeutic effects by the release of secretome, made of both soluble proteins and nano/microstructured extracellular vesicles (EVs). In this work, for the first time, we proved by a proteomic investigation that adipose-derived (AD)-MSC-secretome contains alpha-1-antitrypsin (AAT), the main elastase inhibitor in the lung, 72 other proteins involved in protease/antiprotease balance, and 46 proteins involved in the response to bacteria. By secretome fractionation, we proved that AAT is present both in the soluble fraction of secretome and aggregated and/or adsorbed on the surface of EVs, that can act as natural carriers promoting AAT in vivo stability and activity. To modulate secretome composition, AD-MSCs were cultured in different stimulating conditions, such as serum starvation or chemicals (IL-1β and/or dexamethasone) and the expression of the gene encoding for AAT was increased. By testing in vitro the anti-elastase activity of MSC-secretome, a dose-dependent effect was observed; chemical stimulation of AD-MSCs did not increase their secretome anti-elastase activity. Finally, MSC-secretome showed anti-bacterial activity on Gram-negative bacteria, especially for Klebsiella pneumoniae. These preliminary results, in addition to the already demonstrated immunomodulation, pave the way for the use of MSC-secretome in the treatment of AAT-deficiency lung diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 (A) Proteins secreted by human Adipose-Derived Mesenchymal Stem/Stromal Cells (AD-MSCs) and grouped in four functional categories including protease/peptidase activity, protease/peptidase inhibitor activity, response to bacteria, and acute-phase response (see Table S1); in addition, proteins belonging to a functional category were further split, where possible, by protein families. (B) Topological evaluation of the network (290 nodes and 3836 interactions) reconstructed by combining proteins secreted by human AD-MSCs and Homo sapiens protein-protein interaction (PPI) data [7]. Proteins in the graph showed betweenness, centroid, and degree values above the average calculated on the whole network, thus are considered hubs; the complete list (290 proteins) and the corresponding topological parameters (betweenness, centroid, and degree) are shown in Table S2. (C) Proteins secreted by human AD-MSCs experimentally identified [7] and annotated as SERPINA1 interactors.](https://figures.cochat.ai/paper-figures/61b0309610d84ecdb8398c1c035a4fef/adipose-mesenchymal-extracellular-vesicles-as-alpha-1-antitrypsin-physiological-figure-1.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“VEGF, FGF-2, PDGF, SDF1, CXCL-1, RANTES, MCP-1 and M-CSF are factors present in the MSC secretome known for inducing angiogenesis by binding to their corresponding receptors on endothelial cells and activating the signaling pathways p38/MAPK, PI3K/AKT, MEK/ERK [94], [95], [96].”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 1×
“In fact, EVs entail several advantages as drug delivery vehicles [50]; among all, we consider their ability to protect cargo from degradation [51], stability in the blood circulation, ability to overcome natural barriers [52,53], and intrinsic cell targeting properties.”
BackgroundMaere, S., Heymans, K., & Kuiper, M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti551 · Cited by 4,155
Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data
Doncheva, N. T., Morris, J. H., Gorodkin, J., & Jensen, L. J. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00702 · Cited by 2,306
Concise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
A travel guide to Cytoscape plugins
Saito, R., Smoot, M. E., Ono, K., Ruscheinski, J., Wang, P.-L., Lotia, S., Pico, A. R., Bader, G. D., & Ideker, T. (2012) · Nature Methods · doi:10.1038/nmeth.2212 · Cited by 1,500
Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.164 · Cited by 1,356
Extracellular vesicles for drug delivery.
Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,319
Stoller, J. K., & Aboussouan, L. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66781-5 · Cited by 695
Research works printed but not linked: 1
- Nelson, D.L., and Cox, M.M. (2017). Lehninger Principles of Biochemistry, Springer.
Cited by
Harrell, C. R., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8121605 · Cited by 795
“Importantly, MSC-EVs, in addition to AAT, contained 46 proteins involved in the response to Gram-negative bacteria, implying potent anti-microbial activity of MSC-EVs [51].”
BackgroundResultInfluentialMaumus, M., Rozier, P., Boulestreau, J., Jorgensen, C., & Noël, D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00997 · Cited by 203
Moghadasi, S., Elveny, M., Rahman, H. S., Suksatan, W., Jalil, A. T., Abdelbasset, W. K., Yumashev, A. V., Shariatzadeh, S., Motavalli, R., Behzad, F., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02980-6 · Cited by 203
RetractedMesenchymal stem cell secretome for regenerative medicine: Where do we stand?
Trigo, C. M., Rodrigues, J. S., Camões, S. P., Solá, S., & Miranda, J. P. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.004 · Cited by 252
“VEGF, FGF-2, PDGF, SDF1, CXCL-1, RANTES, MCP-1 and M-CSF are factors present in the MSC secretome known for inducing angiogenesis by binding to their corresponding receptors on endothelial cells and activating the signaling pathways p38/MAPK, PI3K/AKT, MEK/ERK [94–96].”
Li, L., Ngo, H. T. T., Hwang, E., Wei, X., Liu, Y., Liu, J., & Yi, T.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010049 · Cited by 122
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use
Bari, E., Ferrarotti, I., Saracino, L., Perteghella, S., Torre, M. L., & Corsico, A. G. (2020) · Cells · doi:10.3390/cells9040924 · Cited by 126
Self-citationPinky, Gupta, S., Krishnakumar, V., Sharma, Y., Dinda, A. K., & Mohanty, S. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10002-z · Cited by 120
Giovannelli, L., Bari, E., Jommi, C., Tartara, F., Armocida, D., Garbossa, D., Cofano, F., Torre, M. L., & Segale, L. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.06.013 · Cited by 102
Self-citationAbreu, S. C., Lopes-Pacheco, M., Weiss, D. J., & Rocco, P. R. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.600711 · Cited by 86
Understanding exosomes: Part 2—Emerging leaders in regenerative medicine
Miron, R. J., Estrin, N. E., Sculean, A., & Zhang, Y. (2024) · Periodontology 2000 · doi:10.1111/prd.12561 · Cited by 98
Advances in extracellular vesicle functionalization strategies for tissue regeneration
Zheng, D., Ruan, H., Chen, W., Zhang, Y., Cui, W., Chen, H., & Shen, H. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.022 · Cited by 107
Mocchi, M., Dotti, S., Bue, M. D., Villa, R., Bari, E., Perteghella, S., Torre, M. L., & Grolli, S. (2020) · Cells · doi:10.3390/cells9061453 · Cited by 85
Self-citationGurunathan, S., Kang, M.-H., & Kim, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716407 · Cited by 68
Composition, isolation, identification and function of adipose tissue-derived exosomes
Zhao, R., Zhao, T., He, Z., Cai, R., & Pang, W. (2021) · Adipocyte · doi:10.1080/21623945.2021.1983242 · Cited by 72
A Simple and Quick Method for Loading Proteins in Extracellular Vesicles
Busatto, S., Iannotta, D., Walker, S. A., Marzio, L. D., & Wolfram, J. (2021) · Pharmaceuticals · doi:10.3390/ph14040356 · Cited by 66
Lu, X., Fan, S., Cao, M., Liu, D., Xuan, K., & Liu, A. (2024) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-024-00699-2 · Cited by 63
Bari, E., Silvestre, D. D., Mastracci, L., Grillo, F., Grisoli, P., Marrubini, G., Nardini, M., Mastrogiacomo, M., Sorlini, M., Rossi, R., et al. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.08.003 · Cited by 54
Self-citationCystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies
Almughem, F. A., Aldossary, A. M., Tawfik, E. A., Alomary, M. N., Alharbi, W. S., Alshahrani, M. Y., & Alshehri, A. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070616 · Cited by 58
Mocchi, M., Bari, E., Marrubini, G., Bonda, A. F., Perteghella, S., Tartara, F., Cofano, F., Perna, G. D., Giovannelli, L., Mandracchia, D., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081129 · Cited by 49
Self-citationBari, E., Scocozza, F., Perteghella, S., Sorlini, M., Auricchio, F., Torre, M. L., & Conti, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040515 · Cited by 53
Self-citationTranslational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy
Harman, R. M., Marx, C., & de Walle, G. R. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.654885 · Cited by 50
Extracellular Vesicles from Human Adipose-Derived Mesenchymal Stem Cells: A Review of Common Cargos
Alonso-Alonso, M. L., García-Posadas, L., & Diebold, Y. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10155-5 · Cited by 50
Kim, H. J., Kim, G., Lee, J., Lee, Y., & Kim, J. (2021) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-021-00406-4 · Cited by 46
Zhang, E., Phan, P., & Zhao, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.020 · Cited by 42
Regeneration and repair in the healing lung
Lucas, A., Yasa, J., & Lucas, M. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1152 · Cited by 41
Svolacchia, F., Svolacchia, L., Falabella, P., Scieuzo, C., Salvia, R., Giglio, F., Catalano, A. A., Saturnino, C., Lascio, P. D., Guarro, G., et al. (2024) · Medicina · doi:10.3390/medicina60040670 · Cited by 45
Lv, C.-X., Duan, H., Wang, S., Gan, L., & Xu, Q. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00165-y · Cited by 37
The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers
Moloudizargari, M., Asghari, M. H., & Goel, A. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114714 · Cited by 38
Suksatan, W., Chupradit, S., Yumashev, A. V., Ravali, R. S., Shalaby, M. N., Mustafa, Y. F., Kurochkin, A., & Siahmansouri, H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108217 · Cited by 36
Crippa, S., Santi, L., Berti, M., Ponti, G. D., & Bernardo, M. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.663316 · Cited by 40
Orlandi, G., Bari, E., Catenacci, L., Sorrenti, M., Segale, L., Faragò, S., Sorlini, M., Arciola, C. R., Torre, M. L., & Perteghella, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040381 · Cited by 30
Self-citationBari, E., Serra, M., Paolillo, M., Bernardi, E., Tengattini, S., Piccinini, F., Lanni, C., Sorlini, M., Bisbano, G., Calleri, E., et al. (2021) · Cancers · doi:10.3390/cancers13051185 · Cited by 30
Self-citationMesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study
Dauletova, M., Hafsan, H., Mahhengam, N., Zekiy, A. O., Ahmadi, M., & Siahmansouri, H. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108712 · Cited by 29
Bari, E., Ferrarotti, I., Saracino, L., Perteghella, S., Torre, M. L., Richeldi, L., & Corsico, A. G. (2021) · Cells · doi:10.3390/cells10051203 · Cited by 29
Self-citationSears, V. A., Danaoui, Y., & Ghosh, G. (2021) · Materials Today Communications · doi:10.1016/j.mtcomm.2021.102285 · Cited by 31
Miethe, S., Potaczek, D. P., Bazan‐Socha, S., Bachl, M., Schaefer, L., Wygrecka, M., & Garn, H. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00057.2023 · Cited by 24
Hoecke, L. V., Lucci, C., & Vandenbroucke, R. E. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.09.008 · Cited by 28
Mocchi, M., Bari, E., Dotti, S., Villa, R., Berni, P., Conti, V., Bue, M. D., Squassino, G. P., Segale, L., Ramoni, R., et al. (2021) · Animals · doi:10.3390/ani11113271 · Cited by 23
Self-citationBari, E., Roato, I., Perale, G., Rossi, F., Genova, T., Mussano, F. D., Ferracini, R., Sorlini, M., Torre, M. L., & Perteghella, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084064 · Cited by 23
Self-citationExtracellular vesicles and their cells of origin: Open issues in autoimmune diseases
Haghighitalab, A., Dominici, M., Matin, M. M., Shekari, F., Warkiani, M. E., Lim, R., Ahmadiankia, N., Mirahmadi, M., Bahrami, A. R., & Bidkhori, H. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1090416 · Cited by 23
Al-Jipouri, A., Eritja, À., & Božić, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010485 · Cited by 24
Zhao, Z., Yang, S., Zhou, A., Xiao, L., Fang, R., Zhang, S., Zhao, G., & Li, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.732702 · Cited by 22
EVs vs. EVs: MSCs and Tregs as a source of invisible possibilities
Heydari, Z., Peshkova, M., Gonen, Z. B., Coretchi, I., Eken, A., Yay, A. H., Dogan, M. E., Gokce, N., Akalin, H., Kosheleva, N., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02276-2 · Cited by 18
Integrated Strategies for a Holistic View of Extracellular Vesicles
Rondelli, V., Helmy, S., Passignani, G., Parisse, P., & Silvestre, D. D. (2022) · ACS Omega · doi:10.1021/acsomega.2c01003 · Cited by 17
Stem cell therapies: a new era in the treatment of multiple sclerosis
Wu, L., Lü, J., Lan, T., Zhang, D., Xu, H., Kang, Z., Peng, F., & Wang, J. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1389697 · Cited by 22
Bari, E., Tartara, F., Cofano, F., Perna, G. D., Garbossa, D., Perteghella, S., Sorlini, M., Mandracchia, D., Giovannelli, L., Gaetani, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168445 · Cited by 16
Self-citationSoloveva, N. A., Novikova, S. E., Farafonova, T. E., Tikhonova, O. V., & Zgoda, V. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031016 · Cited by 10
Cui, Y., Li, M., Hong, X., Du, D., & Ma, Y. (2020) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2020.100267 · Cited by 8
Mareschi, K., Niclot, A. G. S. B., Marini, E., Bari, E., Labanca, L., Lucania, G., Ferrero, I., Perteghella, S., Torre, M. L., & Fagioli, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084318 · Cited by 7
Self-citationZhang, W., Gan, B., Wang, T., Yang, X., Xue, Y., Zhong, Y., He, X., Peng, X., Zhou, Y., & Cheng, X. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1273113 · Cited by 6
Steering the Clinical Translation of Delivery Systems for Drugs and Health Products
Pignatello, R., & Matricardi, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040350 · Cited by 6
Erratico, S., Belicchi, M., Meregalli, M., Silvestre, D. D., Tripodi, L., Palma, A. D., Jones, R., Ferrari, E., Porretti, L., Trombetta, E., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04284-4 · Cited by 6
Self-citationExtracellular vesicles as carriers for protein and peptide therapeutics delivery: A review
Mengesha, Y., Wondaya, M., Workye, M., & Belete, L. (2025) · Intelligent Pharmacy · doi:10.1016/j.ipha.2025.05.001 · Cited by 7
Zu, T., Gao, M., Liu, B., Zhang, X., & Wu, F. (2025) · Medicine · doi:10.1097/md.0000000000043416 · Cited by 4
Berni, P., Bue, M. D., Conti, V., Andreoli, V., Ramoni, R., Angelone, M., Squassino, G. P., Bari, E., Torre, M. L., Rinaldi, M., et al. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125864 · Cited by 3
Self-citationMarini, A. X., McLoughlin, K. J., Pellegrino, A. R., Tomaraei, G. N., Li, B., Curci, J. A., Bedewy, M., Weinbaum, J. S., & Vorp, D. A. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16110395 · Cited by 4
Perwira, F. D., Utomo, D. N., Widhiyanto, L., & Hernugrahanto, K. D. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns5.11641 · Cited by 2
Mahmoudi, N., Ganjaroudi, N. M., Khaboushan, A. S., Ahmadi, E., Bitaraf, M., Laleh, A., Mehdinejadiani, S., & Zolbin, M. M. (2024) · Qeios · doi:10.32388/ykmeb3.2 · Cited by 2
Extracellular vesicles in pulmonary infection: From pathophysiology to theranostic technologies
Wang, X., Shi, M.-Q., Wang, Y., Zhou, H., Peng, K., Wang, J., Sun, S., Shen, X.-R., Wang, J., Zhao, Z., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155585 · Cited by 3
Extracellular Vesicles: Applications to Regenerative Medicine, Therapeutics and Diagnostics
(2021) · Biomaterials science series · doi:10.1039/9781839164552 · Cited by 5
Updates in the Management of Alpha-1 Antitrypsin Deficiency Lung Disease
Goel, K., Strange, C., Sandhaus, R. A., Petrache, I., & Serban, K. A. (2021) · touchREVIEWS in Respiratory & Pulmonary Diseases · doi:10.17925/usprd.2021.6.1.26 · Cited by 1
Mesenchymal Stromal Cells and their EVs as Potential Leads for SARSCoV2 Treatment
Kia, V., Eshaghi‐Gorji, R., Mansour, R. N., Hassannia, H., Hasanzadeh, E., Gheibi, M., Mellati, A., & Enderami, S. E. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220426115831 · Cited by 1
Kusumawardani, B., Amin, M. N., Rahayu, Y. C., Sari, D. S., Altariq, M. I., Putri, A. H., Kanya, A., Prаhаsаnti, C., & Aljunaid, M. (2024) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2024.05.002 · Cited by 2
Gong, S., Niu, H., Jia, Y., Liu, M., Ren, X., Zhang, D., Shen, J., Yang, C., Lei, Y., Zhao, P., et al. (2025) · Animals · doi:10.3390/ani15091270 · Cited by 1
Gugjoo, M. B. (2025) · Wiley eBooks · doi:10.1002/9781394253289.ch2 · Cited by 1
Zhou, Y., Yamamoto, Y., Xiao, Z., & Ochiya, T. (2020) · Preprints.org · doi:10.20944/preprints202012.0097.v1
Tang, C., Gao, W., You, Y., Pei, X., Zeng, Q., Jiang, W. W., Wu, D., Weng, B., & Zhou, T. (2026) · Future Virology · doi:10.1080/17460794.2026.2661413
Applegate, L. A., Porcello, A., & Laurent, A. E. (2026) · Biomedicines · doi:10.3390/biomedicines14091888
Metadata
- Authors
- Bari, E., Ferrarotti, I., Di Silvestre, D., Grisoli, P., Barzon, V., Balderacchi, A., Torre, M. L., Rossi, R., Mauri, P., Corsico, A. G., & Perteghella, S.
- Affiliations
- University of Pavia (IT)
- Institute for Biomedical Technologies, F.lli Cervi 93, 20090 Segrate, Milan, Italy
- Institute of Biomedical Technologies (IT)
- Corresponding author
- Torre, Maria Luisa
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-08-23
- Volume
- 8
- Issue
- 9
- Pages
- 965
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6770759
- OpenAlex
- W2969490899
- Cited by
- 70
- References
- 69
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 10 · 2023: 4 · 2022: 8 · 2021: 24 · 2020: 12 · 2019: 2
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Regione Lombardia (637541)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- adipose-derived mesenchymal stromal cells, extracellular vesicles, alpha-1-antitrypsin, secretome, lung regeneration, protease-antiprotease balance, anti-elastase activity, antibacterial activity, Klebsiella pneumoniae, serum deprivation, IL-1β, dexamethasone
- MeSH terms
- Extracellular Vesicles, Adult, alpha 1-Antitrypsin, Cells, Cultured, Dexamethasone, Female, Humans, Lung, Middle Aged, Regeneration, Up-Regulation, Adipocytes, Proteomics, Interleukin-1beta, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.